Why will it never be known if convalescent plasma is effective for COVID-19
High expectations have been set around convalescent plasma (CP) for the treatment of COVID-19. However, none of the randomized controlled trials (RCTs) conducted so far have reached their primary endpoints. Herein we report that RCTs of CP disclose a high methodological variability in inclusion crit...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15584
- Acceso en línea:
- https://doi.org/10.1016/j.jtauto.2020.100069
http://hdl.handle.net/20.500.12010/15584
- Palabra clave:
- Coronavirus
COVID-19
SARS-Cov-2
Convalescent plasma
Clinical trials
Randomized
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)